UK Issues Warning After Fake Ozempic Hospitalizations

Hospitalized people suffered diabetic shock and coma, suggesting the pens contained insulin instead of the ingredient semaglutide.
UK Issues Warning After Fake Ozempic Hospitalizations
Mario Tama/Getty Images
|Updated:
0:00

UK authorities cautioned people to be alert against fake Ozempic being distributed in the market following the hospitalization of some individuals who used the products.

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) is “warning the public not to buy pre-filled pens claiming to contain Ozempic (semaglutide) or Saxenda (liraglutide) but to consult a healthcare professional qualified to prescribe medicines and obtain a prescription.” The agency “received reports of a very small number of people who have been hospitalized after using potentially fake weight-loss pens.”
Naveen Athrappully
Naveen Athrappully
Reporter
Naveen Athrappully is a news reporter covering business and world events at The Epoch Times.
Related Topics